Ozkerim, U.; Kinikoglu, O.; Oksuz, S.; Isik, D.; Altintas, Y.E.; Yildirim, S.; Akdag, G.; Surmeli, H.; Odabas, H.; Basoglu, T.;
et al. Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study. Medicina 2026, 62, 99.
https://doi.org/10.3390/medicina62010099
AMA Style
Ozkerim U, Kinikoglu O, Oksuz S, Isik D, Altintas YE, Yildirim S, Akdag G, Surmeli H, Odabas H, Basoglu T,
et al. Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study. Medicina. 2026; 62(1):99.
https://doi.org/10.3390/medicina62010099
Chicago/Turabian Style
Ozkerim, Ugur, Oguzcan Kinikoglu, Sila Oksuz, Deniz Isik, Yunus Emre Altintas, Sedat Yildirim, Goncagul Akdag, Heves Surmeli, Hatice Odabas, Tugba Basoglu,
and et al. 2026. "Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study" Medicina 62, no. 1: 99.
https://doi.org/10.3390/medicina62010099
APA Style
Ozkerim, U., Kinikoglu, O., Oksuz, S., Isik, D., Altintas, Y. E., Yildirim, S., Akdag, G., Surmeli, H., Odabas, H., Basoglu, T., & Turan, N.
(2026). Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study. Medicina, 62(1), 99.
https://doi.org/10.3390/medicina62010099
